Viatris, Inc. (VTRS)
12.67
-0.19
(-1.48%)
USD |
NASDAQ |
Jan 20, 16:00
12.61
-0.06
(-0.47%)
After-Hours: 20:00
Viatris Free Cash Flow: 1.614B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 10.38B |
| Boston Scientific Corp. | 3.824B |
| Amgen, Inc. | 11.54B |
| Moderna, Inc. | -2.663B |
| BioCryst Pharmaceuticals, Inc. | 47.64M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 744.90M |
| Cash from Investing (Quarterly) | -98.90M |
| Cash from Financing (Quarterly) | -228.10M |
| Free Cash Flow Per Share (Quarterly) | 0.554 |
| Free Cash Flow to Equity (Quarterly) | 688.30M |
| Free Cash Flow to Firm (Quarterly) | 2.610B |
| Free Cash Flow Yield | 10.79% |